[Biojava-dev] Missing licence on BlastLikeDataSetCollection.dtd

[Andreas Prlic]

Hi Colin,

Thanks for the info, I updated the file in the SVN repository to contain 
the missing LGPL information.

Andreas


--------------------------------------------------

Andreas Prlic      Wellcome Trust Sanger Institute
                    Hinxton, Cambridge CB10 1SA, UK



On Thu, 10 Jul 2008, Hardman, Colin wrote:

>
>
> Biojava developers,
>
>
>
> Steffen Moller has contacted me about BlastLikeDataSetCollection.dtd
> missing the GNU Lesser General Public License header which is stopping
> it's inclusion in the Debian distribution.
>
>
>
> The original omission was purely accidental - it was always intended to
> be under that license - just like the rest of the CAT contributions.  As
> I don't have/can't remember my cvs access any more would it be possible
> for one you to make the change for me so biojava can be included in free
> software distributions?
>
>
>
> Cheers,
>
>
>
> Colin
>
> --
>
> Colin Hardman
>
> Head of Informatics
>
> MedImmune ( Formally Cambridge Antibody Technology )
>
>
>
>
>
>
>
>
>
>>> Dear Simon,
>
>>>
>
>>> I just contacted Tim Dilks in my role of a developer for the Debian
>
>>> Linux distribution because of a problem that I have with the file
>
>>> dtd/BlastLikeDataSetCollection.dtd that you are the primary author
>
>>> of. It has all rights reserved to CAT without mentionning the free
>
>>> license of BioJava of any sort. My Debian package was rejected by the
>
>
>>> administratives of Debian for that reason.
>
>>>
>
>>> Since my email to the BioJava mailing list about a year ago left the
>
>>> problem untreated, may I ask you to add that license information to
>
>>> the source? I know your time is precious and you may not even have
>
>>> BioJava checked out anywhere anymore, but maybe you could send an
>
>>> email to the developers list and ask to have the license information
> added.
>
>>>
>
>>> With many thanks and best regards,
>
>>>
>
>>> Steffen
>
>>>
>
>>>
>
>>>
>
>>
>
>> Hi Steffen,
>
>>
>
>> I'm not at CAT anymore, so I don't have the (moral) authority to make
>
>> the changes in terms of dealing with license issues.  However, the
>
>> missing FOSS license information was simply an oversight on my part,
>
>> so I'm sure there won't be an issue.
>
>>
>
>> For information, CAT doesn't actually exist as an entity anymore - the
>
>
>> company was acquired by AstraZeneca and then merged with a company
>
>> called MedImmune.   I suggest you contact Colin Hardman at MedImmune -
>
>> he should have the authority to make/request the changes you need.
>
>>
>
>>
>
>> Hope this helps,
>
>>
>
>> Simon
>
>
>
>
> To the extent this electronic communication or any of its attachments contain information that is not in the public domain, such information is considered by MedImmune to be confidential and proprietary.  This communication is expected to be read and/or used only by the individual(s) for whom it is intended.  If you have received this electronic communication in error, please reply to the sender advising of the error in transmission and delete the original message and any accompanying documents from your system immediately, without copying, reviewing or otherwise using them for any purpose.  Thank you for your cooperation.
>
> _______________________________________________
> biojava-dev mailing list
> biojava-dev at lists.open-bio.org
> http://lists.open-bio.org/mailman/listinfo/biojava-dev
>


-- 
 The Wellcome Trust Sanger Institute is operated by Genome Research 
 Limited, a charity registered in England with number 1021457 and a 
 company registered in England with number 2742969, whose registered 
 office is 215 Euston Road, London, NW1 2BE.